Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Affymetrix to Market GeneData Microarray Expression Analysis Software

This article has been updated from a previous version.  

NEW YORK, April 9 - Affymetrix has signed an agreement with GeneData of Basel, Switzerland, to market the company's GeneData Expressionist software for analysis of microarray gene expression data, the companies said Monday. 

Under the non-exclusive agreement, Affymetrix will market the Expressionist software with its GeneChip microarrays and with its software, and the companies will work together to ensure their products work together seamlessly. The companies did not disclose financial details of the agreement. 

Even though Affymetrix offers its own microarray software, the company sought to partner with GeneData, a privately held company that has branches in Munich and San Francisco, in order to add to its offerings in higher volume analysis.

"Our higher through-put customers asked us to provide them a more scalable UNIX-based solution that allows them to manage, analyze, and integrate the very large amounts of genomic data our technology generates with other genomic and proteomic data they generate, and GeneData can help us provide that today," said Affymetrix spokeswoman Holly Hartz. 

Affymetrix currently markets a Microarray suite of software for viewing of GeneChip images; MicroDB software for microarray data management and storage in low-volume Microarray labs and Laboratory Information Management System for high-volume labs; and the Data Mining Tool for analysis of expression results from GeneChips. The company also markets Jaguar software for analysis of spotted array data.   

"Our internal software development efforts are currently focused on software for running our instrumentation; capturing, managing, and analyzing expression data at a laboratory or small departmental level; developing databases for probe array design, and developing Internet-based delivery mechanisms for associated probe array sequence and annotation information," Hartz said.

GeneData joins a number of bioinformatics companies, including Spotfire and Rosetta Inpharmatics, which have sought to fill in the gaps Affymetrix has left open in microarray analysis.  

GeneData has sold its gene and protein expression data analysis tools to customers including Altana, Aventis, Bayer, Boehringer Ingelheim, diaDexus, F. Hoffmann-La Roche, MediGene, MWG-Biotech, Novartis, Schering, and Syngenta.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.